Bio

Susanne joined Amadeus in 2023 and is a Partner in Amadeus’ European early-growth deep tech strategy.

She is a professional venture capital investor and angel since 2014 and has led and co-led more than 20 investments in deeptech including health and biotech.

Susanne was previously a Partner at Verve Ventures. She has served as board member or observer on several of her portfolio companies such as: CREAL, a leader in lightfield technology for VR and AR; antibody discovery platform MemoTherapeutics; high throughput organism-on-chip animal testing alternative Nagi Bioscience; retinal biomarker company Earlysight, AI assisted diagnostics provider Medimaps; breakthrough oral delivery system plaform Biograil and next generation gene therapy company Somagenetix.